269 related articles for article (PubMed ID: 7727461)
21. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
23. Benefits of avoidance of induction immunosuppression in heart transplantation.
Menkis AH; McKenzie FN; Thomson D; Jones M; Pflugfelder P; Kostuk WJ; Stiller CR
J Heart Transplant; 1989; 8(4):311-4. PubMed ID: 2671316
[TBL] [Abstract][Full Text] [Related]
24. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P
J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
[TBL] [Abstract][Full Text] [Related]
25. Heart transplantation in females.
Esmore D; Keogh A; Spratt P; Jones B; Chang V
J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
[TBL] [Abstract][Full Text] [Related]
26. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
28. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.
Lake KD; Reutzel TJ; Pritzker MR; Jorgensen CR; Emery RW
J Heart Lung Transplant; 1993; 12(4):580-90. PubMed ID: 8369320
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
30. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
32. Successful withdrawal of corticosteroids in heart transplantation.
Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
[TBL] [Abstract][Full Text] [Related]
33. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
[No Abstract] [Full Text] [Related]
34. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
35. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
[No Abstract] [Full Text] [Related]
36. Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression.
Reid KR; Menkis AH; Novick RJ; Pflugfelder PW; Kostuk WJ; Reid J; Whitby JL; Powell AM; McKenzie FN
J Heart Lung Transplant; 1991; 10(6):894-900. PubMed ID: 1756154
[TBL] [Abstract][Full Text] [Related]
37. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation.
Butman SM; Wild JC; Nolan PE; Fagan TC; Finley PR; Hicks MJ; Mackie MJ; Copeland JG
J Heart Lung Transplant; 1991; 10(3):351-8. PubMed ID: 1854763
[TBL] [Abstract][Full Text] [Related]
39. Are steroids essential for successful maintenance of immunosuppression in heart transplantation?
Katz MR; Barnhart GR; Szentpetery S; Rider S; Thompson JA; Hess M; Hastillo A; Lower RR
J Heart Transplant; 1987; 6(5):293-7. PubMed ID: 3316555
[TBL] [Abstract][Full Text] [Related]
40. Increased rejection in gender-mismatched grafts: amelioration by triple therapy.
Keogh AM; Valantine HA; Hunt SA; Schroeder JS; Oyer PE
J Heart Lung Transplant; 1991; 10(1 Pt 1):106-10. PubMed ID: 2007161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
